Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 58.85
-0.65 (-1.09%)
May 28, 2026, 10:20 AM HKT
Keymed Biosciences Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Keymed Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $93.06. The average 1-year stock price forecast is 58.13% higher than the current stock price, while the lowest is $85.95 (+46.05%) and the highest is $102.95 (+74.94%).
Price Target: $93.06 (+58.13%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 4, 2026.
Analyst Ratings
The average analyst rating for Keymed Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 7 | 6 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst KeyBanc No rating | KeyBanc | Buy Maintains $87.31 | Buy | Maintains | $87.31 | +48.36% | Apr 4, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $91.08 → $91.13 | Buy | Maintains | $91.08 → $91.13 | +54.85% | Mar 30, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $78.00 | Buy | Maintains | $78.00 | +32.54% | Mar 24, 2026 |
Unknown Analyst Sinolink Securities No rating | Sinolink Securities | Buy Maintains $83.29 | Buy | Maintains | $83.29 | +41.53% | Dec 26, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.